Mark Smolinski

Mark Smolinski
MD, MPH, Ending Pandemics, San Francisco, California, USA

Dr. Mark Smolinski brings over 25 years of experience in applying innovative solutions to improve disease prevention and control across the globe. As president of Ending Pandemics, he leads a team of innovators working to improve early disease detection and rapid response in the planetary hotpots for emerging diseases. 

Since 2009, he has served as the Chief Medical Officer and Director of Global Health at the Skoll Global Threats Fund (SGTF) until Ending Pandemics spun out as an independent entity in 2018.

Prior to SGTF, Mark was part of the starting team at, Google’s philanthropic arm, Vice President for Biological Programs at the Nuclear Threat Initiative, and study director at the National Academy of Medicine for the 2003 landmark report, Microbial Threats To Health. He was the sixth Luther Terry Fellow in the Office of the U.S. Surgeon General and an Epidemic Intelligence Officer with the U.S. CDC.

During COVID, Mark was appointed to the National Academy of Medicine’s Standing Committee on Emerging Threats in the 21st Century. He received his MD from the University of Michigan and M.P.H. from the University of Arizona, with board certification in preventive medicine and public health.